🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Administration of low-dose selective noradrenaline reuptake inhibitor (sNRI...
Status
Recruiting
Location
Institut de Neuromodulation
Start Date
2025-11-18
Trial ID
NCT07239791
Treatments Being Tested
The purpose of this study is to evaluate atomoxetine's effects on the rewar...
Status
Withdrawn
Location
West Haven Veterans Affairs
Start Date
2014-04
Trial ID
NCT02046551
Treatments Being Tested
The purpose of this protocol is to investigate the acute treatment efficacy...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2004-02
Trial ID
NCT00485459
Treatments Being Tested
Persistent obstructive sleep apnea (OSA) is common in people treated with m...
Status
Recruiting
Location
Sleep Disorders Research Program Brigham and Women's Hospital
Start Date
2023-07-01
Trial ID
NCT05293600
Treatments Being Tested
This study will evaluate the effectiveness of atomoxetine in treating child...
Status
Completed
Location
Christian Sarkine Autism Treatment Center at Riley Hospital for Children
Start Date
2007-07
Trial ID
NCT00498173
Treatments Being Tested
This proposal evaluates the safety and effectiveness of a noradrenergic dru...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT02788357
Treatments Being Tested
A single arm, open-label, phase 3 multicenter study to evaluate the effecti...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2004-10
Trial ID
NCT00191516
Treatments Being Tested
Reduction of volume of the hippocampus has been associated with major depre...
Status
Completed
Location
University of Ottawa Institute of Mental Health Research
Start Date
2005-02
Trial ID
NCT00704860
Treatments Being Tested
The purpose of this study is to evaluate the safety of atomoxetine and its ...
Status
Completed
Location
Emory University School of Medicine
Start Date
2012-03
Trial ID
NCT01522404
Treatments Being Tested
The purpose of this study is to examine the efficacy of atomoxetine (ATX) t...
Status
Completed
Location
Yale University School of Medicine
Start Date
2004-05
Trial ID
NCT00611533
Treatments Being Tested